Glycoxidized low-density lipoprotein enhances monocyte chemoattractant protein-1 mRNA expression in human umbilical vein endothelial cells: Relation to lysophosphatidylcholine contents and inhibition by nitric oxide donor

Metabolism: Clinical and Experimental

Volumn 51, Issue 9, 2002, Pages 1135-1142

  Sonoki, Kazuo ^a   Yoshinari, Mototaka ^a   Iwase, Masanori ^a   Iino, Kenzo ^a   Ichikawa, Kojiro ^a   Ohdo, Shigehiro ^a   Higuchi, Shun ^a   Iida, Mitsuo ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LOW DENSITY LIPOPROTEIN; LYSOPHOSPHATIDYLCHOLINE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; OXIDIZED LOW DENSITY LIPOPROTEIN; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ARTICLE; ATHEROSCLEROSIS; DIABETES MELLITUS; DNA BINDING; ENDOTHELIUM CELL; GLYCATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; OXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STIMULATION; UMBILICAL VEIN;

EID: 0036739001     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1053/meta.2002.34703     Document Type: Article

References (49)

1. Cohen M.P., Lautenslager G, Shea E: Glycated LDL concentrations in non-diabetic and diabetic subjects measured with monoclonal antibodies reactive with glycated apolipoprotein B epitopes. Eur J Clin Chem Clin Biochem 31:707-713, 1993
2. Klein RL, Laimins M, Lopez-Virella MF: Isolation, characterization, and metabolism of the glycated and nonglycated subfractions of low-density lipoproteins isolated from type I diabetic patients and nondiabetic subjects. Diabetes 44:1093-1098, 1995
3. Kobayashi K, Watanabe J, Umeda F, et al: Glycation accelerates the oxidation of low density lipoprotein by copper ions. Endocrinol J 42:461-465, 1995
4. Bowie A, Owens D, Collins P, et al: Glycosylated low density lipoprotein is more sensitive to oxidation: Implications for the diabetic patient? Atherosclerosis 102:63-67, 1993
5. Imagawa Y, Sakata N, Takebayashi S. et al: In vivo and in vitro evidence for the glycoxidation of low density lipoprotein in human atherosclerotic plaques. Atherosclerosis 150:343-355, 2000
6. Cushing SD, Berliner JA, Valente AJ, et al: Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci USA 87:5134-5138, 1990
7. Tsao PS, Wang BY, Buitrago R, et al: Nitric oxide regulates monocyte chemotactic protein-1. Circulation 96:934-940, 1997
8. Klouche M, Gottschling S, Gerl V, et al: Atherogenic properties of enzymatically degraded LDL: Selective induction of MCP-1 and cytotoxic effects on human macrophages. Arterioscler Thromb Vasc Biol 18:1376-1385, 1998
9. Yla-Herttuala S, Lipton BA, Rosenfeld ME, et al: Expression of monocyte chemoattractant protein 1 in macrophage rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA 88:5252-5256, 1991
10. Nelken NA, Coughin SR, Gordon D, et al: Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 88:1121-1127, 1991
11. Navab M, Imes SS, Hama SY, et al: Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. J Clin Invest 88:2039-2046, 1991
12. Collins T: Endothelial nuclear factor-κB and initiation of the atherosclerotic lesion. Lab Invest 68:499-508, 1993
13. Garg UC, Hassid A: Nitric-oxide generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83:1774-1777, 1989
14. Boulanger C, Luscher T: Release of endothelin from the porcine aorta: Inhibition by endothelium-derived nitric oxide. J Clin Invest 85:587-590, 1990
15. Kubes P, Suzuki M, Granger D.N: Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 88:4651-4655, 1991
16. Zeiher AM, Fisslthaler B, Schray-Utz B, et al: Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells. Circ Res 76:980-986, 1995
17. Jaffe EA, Nachman RL, Becker CG, et al: Culture of human endothelial cells derived from umbilical veins. J Clin Invest 52:2745-2756, 1973
18. Vieira OV, Laranjinha JAN, Madeira VMC, et al: Rapid isolation of low density lipoproteins in a concentrated fraction free from water-soluble plasma antioxidants. J Lipid Res 37:2715-2721, 1996
19. Yagi K: A simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 15:212-216, 1976
20. Watson AD, Leitinger N, Navab M, et al: Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J Biol Chem 272:13597-13607, 1997
21. Bligh EG, Bayer WJ, A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911-917, 1959
22. Kaluzny MA, Duncan LA, Merritt MV, et al: Rapid separation of lipid classes in high yield and purity using bonded phase columns. J Lipid Res 26:135-140, 1985
23. Han X, Gubitosi-Klug RA, Collins BJ, et al: Alterations in individual molecular species of human platelet phospholipids during thrombin stimulation: Electrospray ionization mass spectrometry-facilitated identification of the boundary conditions for the magnitude and selectivity of thrombin-induced platelet phospholipid hydrolysis. Biochemistry 35:5822-5832, 1996
24. Schreiber E, Matthias P, Muller MM, et al: Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res 17:6419, 1989
25. Parhami F, Fang ZT, Fogelman AM, et al: Minimally modified low density lipoprotein-induced inflammatory responses in endothelial cells are mediated by cyclic adenosine monophosphate. J Clin Invest 92:471-478, 1993
26. Li D, Mehta JL: Antisense to LOX-1 inhibits oxidized LDL-mediated upregulation of monocyte chemoattractant protein-1 and monocyte to human coronary artery endothelial cells. Circulation 101:2889-2895, 2000
27. Kobayashi K, Watanabe J, Umeda F, et al: Metabolism of oxidized glycated low-density lipoprotein in cultured bovine aortic endothelial cells. Horm Metab Res 27:356-362, 1995
28. Bucala R, Makita Z, Koschinsky T, et al: Lipid advanced glycosylation: pathway of lipid oxidation in vivo. Proc Natl Acad Sci USA 90:6434-6438, 1993
29. Yan SD, Schmidt AM, Anderson GM, et al: Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem 269:9889-9897, 1994
30. Bierhaus A, Illmer T, Kasper M, et al: Advanced glycation end product (AGE)-mediated induction of tissue factor in cultured endothelial cells is dependent on RAGE. Circulation 96:2262-2271, 1997
31. Schmidt AM, Hori O, Chen JX, et al: Advanced glycation endproducts interacting with their endothelial receptor induced expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. J Clin Invest 96:1395-1403, 1995
32. Lopes-Virella MF, Klein RL, Lyons TJ, et al: Glycosylation of low-density lipoprotein enhances cholesteryl ester synthesis in human monocyte-derived macrophages. Diabetes 37:550-557, 1988
33. Khan BV, Parthasarathy SS, Alexander RW, et al: Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J Clin Invest 95:1262-1270, 1995
34. Sakurai T, Kimura S, Nakano M, et al: Oxidative modification of glycated low density lipoprotein in the presence of iron. Biochem Biophys Res Commun 177:433-439, 1991
35. Sugiyama S, Kugiyama K, Ogata N, et al: Biphasic regulation of transcription factor nuclear factor-κB activity in human endothelial cells by lysophosphatidylcholine through protein kinase C-mediated pathway. Arterioscler Thromb Vasc Biol 18:568-576, 1998
36. Takahara N. Kashiwagi A, Maegawa H, et al: lysophosphatidylcholine stimulates the expression and production of MCP-1 by human vascular endothelial cells. Metabolism 45:559-564, 1996
37. Ohara Y, Peteson TE, Kuo BZJF, et al: Lysophosphatidylcholine increases vascular superoxide anion production via protein kinase C activation. Arterioscler Thromb 14:1007-1013, 1994
38. Kugiyama K, Sugiyama S, Ogata N, et al: Burst production of superoxide anion in human endothelial cells by lysophosphatidylcholine. Atherosclerosis 143:201-204, 1999
39. Marumo T, Schini-Kerth VB, Fisslthaler B, et al: Platelet-derived growth factor-stimulated superoxide anion production modulates activation of transcription factor NF-κB and expression of monocyte chemoattractant protein 1 in human aortic smooth muscle cells. Circulation 96:2361-2367, 1997
40. Satriano JA, Shuldiner M, Hora K, et al: Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/MCP-1, and the monocyte colony-stimulating factor, CSF-1, in response to tumor necrosis factor-α and immunoglobulin G: Evidence for involvement of reduced nicotinamide adenine dinucleotide phosphate (NADPH)-dependent oxidase. J Clin Invest 92:1564-1571, 1993
41. Shi AH, Yoshinari M, Wakisaka M, et al: Lysophosphatidylcholine molecular species in low density lipoprotein of type 2 diabetes. Horm Metab Res 31:283-286, 1999
42. Nakano T, Raines EW, Abraham JA, et al: Lysophosphatidylcholine upregulates the level of heparin-binding epidermal growth factor-like growth factor mRNA in human monocytes. Proc Natl Acad Sci USA 91:1069-1073, 1994
43. 2+ sensitivity in a-toxin-permeabilized small mesenteric artery from the rat. Br J Pharmacol 117:1238-1244, 1996
44. Murohara T, Scalia R, Lefer AM: Lysophosphatidylcholine promotes p-selectin expression in platelets and endothelial cells: Possible involvement of protein kinase C activation and its inhibition by nitric oxide donors. Circ Res 78:780-789, 1996
45. Katsuyama K, Shichiri M, Marumo F, et al: NO inhibits cytokine-induced iNOS expression and NFκB activation by interfering with phosphorylation and degradation of IκB-α. Arterioscler Thromb Vasc Biol 18:1796-1802, 1998
46. Spiecker M, Peng HB, Liao JK: Inhibition of endothelial vascular cell adhesion molecule-1 expression by nitric oxide involves the induction and nuclear translocation of IκBα. J Biol Chem 272:30969-30974, 1997
47. Giugliano D, Marfella R, Coppola L, et al: Vascular effects of acute hyperglycemia in humans are reversed by L-arginine: Evidence for reduced availability of nitric oxide during hyperglycemia. Circulation 95:1783-1790, 1997
48. Heitzer T, Krohn K, Albers S, et al: Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with type II diabetic mellitus. Diabetologia 43:1435-1438, 2000
49. O'Byrne S, Forte P, Roberts LJ, et al: Nitric oxide synthesis and isoprostane production in subjects with type I diabetes and normal urinary albumin excretion. Diabetes 49:857-862, 2000